In order to investigate the ability of CD38+ NK cells and CEA to evaluate lymph node status in early-stage CRC, we compared the proportions of CD38+ NK cells between T1/T2-stage patients with LNM and those without. The gene discussed is CEACAM5; the disease is colorectal carcinoma.